États-Unis · Plateformes & données · MarketBeat

Insmed, Inc. (INSM) - What Are Brokerages Thinking About This Stock?

Publié par MarketBeat · États-Unis il y a 1 h

Insmed, Inc. (NASDAQ:INSM - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-five analysts that are presently covering the company,…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Insmed, Inc. (INSM) - What Are Brokerages Thinking About This Stock?

À lire aussi

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Japan's 20-Year Government Bond Auction Draws Record Demand

AI applications expand, fueling China's economic growth

ASTS Stock Slips Overnight: Viasat Urges FCC To Reject AST SpaceMobile’s ‘Fatally Flawed’ Overseas Spectrum Bid

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

Insmed, Inc. (INSM) - What Are Brokerages Thinking About This Stock?

Partager

À lire aussi

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Japan's 20-Year Government Bond Auction Draws Record Demand

AI applications expand, fueling China's economic growth

ASTS Stock Slips Overnight: Viasat Urges FCC To Reject AST SpaceMobile’s ‘Fatally Flawed’ Overseas Spectrum Bid

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.